annual current liabilities:
$47.40M+$26.12M(+122.80%)Summary
- As of today (July 1, 2025), PTGX annual total current liabilities is $47.40 million, with the most recent change of +$26.12 million (+122.80%) on December 31, 2024.
- During the last 3 years, PTGX annual current liabilities has risen by +$3.38 million (+7.68%).
- PTGX annual current liabilities is now at all-time high.
Performance
PTGX Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$35.11M-$12.29M(-25.92%)Summary
- As of today (July 1, 2025), PTGX quarterly total current liabilities is $35.11 million, with the most recent change of -$12.29 million (-25.92%) on March 1, 2025.
- Over the past year, PTGX quarterly current liabilities has dropped by -$4.80 million (-12.02%).
- PTGX quarterly current liabilities is now -32.80% below its all-time high of $52.25 million, reached on September 30, 2017.
Performance
PTGX quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
PTGX Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +122.8% | -12.0% |
| 3 y3 years | +7.7% | -19.2% |
| 5 y5 years | +33.9% | -3.5% |
PTGX Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +122.8% | -25.9% | +65.0% |
| 5 y | 5-year | at high | +122.8% | -25.9% | +65.0% |
| alltime | all time | at high | +3411.0% | -32.8% | +1023.2% |
PTGX Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $35.11M(-25.9%) |
| Dec 2024 | $47.40M(+122.8%) | $47.40M(+6.3%) |
| Sep 2024 | - | $44.58M(+7.2%) |
| Jun 2024 | - | $41.58M(+4.2%) |
| Mar 2024 | - | $39.91M(+87.6%) |
| Dec 2023 | $21.27M(-31.8%) | $21.27M(-23.7%) |
| Sep 2023 | - | $27.87M(+5.6%) |
| Jun 2023 | - | $26.40M(+13.6%) |
| Mar 2023 | - | $23.23M(-25.5%) |
| Dec 2022 | $31.18M(-29.2%) | $31.18M(-15.2%) |
| Sep 2022 | - | $36.75M(-8.3%) |
| Jun 2022 | - | $40.09M(-7.8%) |
| Mar 2022 | - | $43.46M(-1.3%) |
| Dec 2021 | $44.02M(+9.4%) | $44.02M(+12.4%) |
| Sep 2021 | - | $39.16M(-8.9%) |
| Jun 2021 | - | $42.97M(+24.5%) |
| Mar 2021 | - | $34.52M(-14.2%) |
| Dec 2020 | $40.24M | $40.24M(+4.4%) |
| Sep 2020 | - | $38.56M(+9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $35.36M(-2.8%) |
| Mar 2020 | - | $36.37M(+2.7%) |
| Dec 2019 | $35.41M(+35.4%) | $35.41M(+15.0%) |
| Sep 2019 | - | $30.78M(-7.6%) |
| Jun 2019 | - | $33.32M(+36.0%) |
| Mar 2019 | - | $24.50M(-6.3%) |
| Dec 2018 | $26.16M(-38.5%) | $26.16M(+8.5%) |
| Sep 2018 | - | $24.10M(-16.9%) |
| Jun 2018 | - | $29.02M(-14.5%) |
| Mar 2018 | - | $33.92M(-20.3%) |
| Dec 2017 | $42.55M(+561.3%) | $42.55M(-18.6%) |
| Sep 2017 | - | $52.25M(+457.8%) |
| Jun 2017 | - | $9.37M(+20.4%) |
| Mar 2017 | - | $7.78M(+20.9%) |
| Dec 2016 | $6.43M(+105.9%) | $6.43M(+20.3%) |
| Sep 2016 | - | $5.35M(+30.1%) |
| Jun 2016 | - | $4.11M(-8.1%) |
| Mar 2016 | - | $4.47M(+43.0%) |
| Dec 2015 | $3.13M(+131.6%) | $3.13M |
| Dec 2014 | $1.35M | - |
FAQ
- What is Protagonist Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual current liabilities year-on-year change?
- What is Protagonist Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly current liabilities year-on-year change?
What is Protagonist Therapeutics annual total current liabilities?
The current annual current liabilities of PTGX is $47.40M
What is the all time high annual current liabilities for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual total current liabilities is $47.40M
What is Protagonist Therapeutics annual current liabilities year-on-year change?
Over the past year, PTGX annual total current liabilities has changed by +$26.12M (+122.80%)
What is Protagonist Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of PTGX is $35.11M
What is the all time high quarterly current liabilities for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly total current liabilities is $52.25M
What is Protagonist Therapeutics quarterly current liabilities year-on-year change?
Over the past year, PTGX quarterly total current liabilities has changed by -$4.80M (-12.02%)